Satyaveni Malasala

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin et al. · The Lancet · 2024 · 2.1K citations · Full text

Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus

Srikanth Gatadi, Jitendra Gour, Manjulika Shukla et al. · European Journal of Medicinal Chemistry · 2018 · 67 citations

Antimicrobial Drug Discovery, Antibiotics, Potent Antibacterial Agents +8

Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis

Satyaveni Malasala, Mohammad Naiyaz Ahmad, Ravikumar Akunuri et al. · European Journal of Medicinal Chemistry · 2020 · 63 citations

Antimicrobial Drug Discovery, Potent Anti-microbial Agents, Antibiotics +13

Facile synthesis of 1,2,3-triazole-fused indolo- and pyrrolo[1,4]diazepines, DNA-binding and evaluation of their anticancer activity

Jitendra Gour, Srikanth Gatadi, Venkatesh Pooladanda et al. · Bioorganic Chemistry · 2019 · 43 citations

Medicinal Chemistry, Engineering, Medicine +9

Synthesis and evaluation of new 4(3H)-Quinazolinone derivatives as potential anticancer agents

Srikanth Gatadi, Gauthami Pulivendala, Jitendra Gour et al. · Journal of Molecular Structure · 2019 · 35 citations

Medicinal Chemistry, Derivative (Chemistry), Bioorganic Chemistry +12